Ecology meets cancer biology: The cancer swamp promotes the lethal cancer phenotype

Oncotarget

Volumn 6, Issue 12, 2015, Pages 9669-9678

  Amend, Sarah R ^a   Pienta, Kenneth J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoeutrophication; Cancer hallmarks; Ecosystem; Lethal phenotype; Selection

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; HYPOXIA INDUCIBLE FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1;

ANAEROBIC FERMENTATION; ARTICLE; BONE PAIN; CACHEXIA; CANCER THERAPY; CELL HOMING; CYTOKINE RELEASE; ECOLOGY; ENVIRONMENTAL CHANGE; EUTROPHICATION; EXTRACELLULAR MATRIX; HUMAN; HYPOXIA; INVASIVE SPECIES; LEUKEMIA; MACROPHAGE; METASTASIS; NEOPLASM; NONHUMAN; NUTRIENT CYCLING; OXIDATIVE PHOSPHORYLATION; SOLID TUMOR; THROMBOSIS; TUMOR INVASION; TUMOR MICROENVIRONMENT; ANIMAL; CELL COMMUNICATION; GENETIC EPIGENESIS; HOMEOSTASIS; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; EPIGENESIS, GENETIC; HOMEOSTASIS; HUMANS; HYPOXIA; NEOPLASMS; PHENOTYPE; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84929600784     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3430     Document Type: Article

References (71)

1. Paget G. Remarks on a Case of Alternate Partial Anaesthesia. British medical journal. 1889; 1:1-3.
2. Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nature reviews Cancer. 2011; 11:411-425.
3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100:57-70.
4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144:646-674.
5. Merlo LM, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. Nature reviews Cancer. 2006; 6:924-935.
6. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012; 21:309-322.
7. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nature medicine. 2013; 19:1423-1437.
8. Pienta KJ, Robertson BA, Coffey DS, Taichman RS. The cancer diaspora: Metastasis beyond the seed and soil hypothesis. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013; 19:5849-5855.
9. Pienta KJ, McGregor N, Axelrod R, Axelrod DE. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Translational oncology. 2008; 1:158-164.
10. Eugene P, Odum GWB. Fundamentals of Ecology:Thomson Brooks/Cole. 2005.
11. Tansley AG. The use and abuse of vegetational concepts and terms. Ecology. 1935; 16:284-307.
12. Krebs CJ. The message of ecology: Indo American Books. 2007.
13. McClain ME, Bilby RE, Triska FJ. Nutrient cycles and responses to disturbance. River ecology and management:Lessons from the Pacific coastal ecoregion. 1998; 347-372.
14. Davidson AM, Jennions M, Nicotra AB. Do invasive species show higher phenotypic plasticity than native species and, if so, is it adaptive? A meta-analysis. Ecology letters. 2011; 14:419-431.
15. Kolar CS, Lodge DM. Progress in invasion biology: predicting invaders. Trends in Ecology & Evolution. 2001; 16:199-204.
16. Yang KR, Mooney SM, Zarif JC, Coffey DS, Taichman RS, Pienta KJ. Niche inheritance: a cooperative pathway to enhance cancer cell fitness though ecosystem engineering. Journal of cellular biochemistry. 2014; 115:1478-1485.
17. Erwin DH. Macroevolution of ecosystem engineering, niche construction and diversity. Trends in Ecology & Evolution. 2008; 23:304-310.
18. Vitousek PM. Concepts of Ecosystem Ecolog. A Comparative View. Pomeroy L.R, Alberts J.J. Springer-Verlag New York. 1988. xii, 384 pp., illus. $72. Ecological Studies, vol. 67 Based on a conference. Science. 1989; 243:825-826.
19. Vitousek PM, Walker LR, Whiteaker LD, Mueller-Dombois D, Matson PA. Biological Invasion by Myrica faya Alters Ecosystem Development in Hawaii. Science. 1987; 238:802-804.
20. Ehrenfeld JG. Effects of exotic plant invasions on soil nutrient cycling processes. Ecosystems. 2003; 6:503-523.
21. Rice E. Allelopathic effects on nitrogen cycling. Allelopathy: Springer. 1992; 31-58.
22. Van Vuuren M, Aerts E, Berendse F, De Visser W. Nitrogen mineralization in heathland ecosystems dominated by different plant species. Biogeochemistry. 1992; 16:151-166.
23. Van Vuuren MM, Berendse F. Changes in soil organic matter and net nitrogen mineralization in heathland soils, after removal, addition or replacement of litter from Erica tetralix or Molinia caerulea. Biology and Fertility of Soils. 1993; 15:268-274.
24. Nixon SW. Coastal marine eutrophication: a definition, social causes, and future concerns. Ophelia. 1995; 41:199-219.
25. Callisto M, Molozzi J, Barbosa JLE. Eutrophication of Lakes. Eutrophication: Causes, Consequences and Control:Springer. 2014; 55-71.
26. Nagar B, Datta M, Khakhar M, Indian J. Eutrophication and recovery in experimental lakes: implications for lake management. 1974.
27. Khan MN, Mohammad F. Eutrophication: challenges and solutions. Eutrophication: Causes, Consequences and Control: Springer. 2014; 1-15.
28. Francis G. Poisonous Australian Lake. Nature. 1878; 18.
29. Landsberg JH. The effects of harmful algal blooms on aquatic organisms. Reviews in Fisheries Science. 2002; 10:113-390.
30. Watts AC, Kobziar LN. Smoldering Combustion in Organic Soils: Peat and Muck Fires in the Southeastern US.
31. Singh AK, Singh R, Singh MP, Chandra H, Shukla N. Mine fire gas indices and their application to Indian underground coal mine fires. International Journal of coal geology. 2007; 69:192-204.
32. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer metastasis reviews. 2006; 25:9-34.
33. Burkholder B, Huang RY, Burgess R, Luo S, Jones VS, Zhang W, Lv ZQ, Gao CY, Wang BL, Zhang YM, Huang RP. Tumor-induced perturbations of cytokines and immune cell networks. Biochimica et biophysica acta. 2014; 185:182-201.
34. Catalano V, Turdo A, Di Franco S, Dieli F, Todaro M, Stassi G. Tumor and its microenvironment: a synergistic interplay. Seminars in cancer biology. 2013; 23:522-532.
35. Folkman J. Toward an understanding of angiogenesis:search and discovery. Perspect Biol Med. 1985; 29:10-36.
36. Zheng J. Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). Oncology letters. 2012; 4:1151-1157.
37. Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer cell. 2006; 9:425-434.
38. Kim CH, Ko AR, Lee SY, Jeon HM, Kim SM, Park HG, Han SI, Kang HS. Hypoxia switches glucose depletioninduced necrosis to phosphoinositide 3-kinase/Aktdependent apoptosis in A549 lung adenocarcinoma cells. International journal of oncology. 2010; 36:117-124.
39. Steinbach J, Wolburg H, Klumpp A, Probst H, Weller M. Hypoxia-induced cell death in human malignant glioma cells: energy deprivation promotes decoupling of mitochondrial cytochrome c release from caspase processing and necrotic cell death. Cell Death & Differentiation. 2003; 10:823-832.
40. Loberg RD, Bradley DA, Tomlins SA, Chinnaiyan AM, Pienta KJ. The lethal phenotype of cancer: the molecular basis of death due to malignancy. CA: a cancer journal for clinicians. 2007; 57:225-241.
41. Narsale AA, Carson JA. Role of interleukin-6 in cachexia:therapeutic implications. Current opinion in supportive and palliative care. 2014; 8:321-327.
42. Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nature reviews Drug discovery. 2014; 14:58-74.
43. Lozano-Ondoua AN, Symons-Liguori AM, Vanderah TW. Cancer-induced bone pain: Mechanisms and models. Neuroscience letters. 2013; 557 Pt A:52-59.
44. Andrea N, Ansell J. Management of thrombosis in the cancer patient. The journal of supportive oncology. 2003; 1: 235-238, 240-232; discussion 239-240, 243-235.
45. Shelke AR, Khorana AA. Cancer-associated thrombosis: an update. Drug Discovery Today: Disease Mechanisms. 2011; 8:e39-e45.
46. Day RL, Laland KN, Odling-Smee FJ. Rethinking adaptation:the niche-construction perspective. Perspectives in biology and medicine. 2003; 46:80-95.
47. Odling-Smee J, Erwin DH, Palkovacs EP, Feldman MW, Laland KN. Niche construction theory: a practical guide for ecologists. The Quarterly review of biology. 2013; 88:3-28.
48. Laland KN, Boogert NJ. Niche construction, co-evolution and biodiversity. Ecological economics. 2010; 69:731-736.
49. Greaves M, Maley CC. Clonal evolution in cancer. Nature. 2012; 481:306-313.
50. Nowell PC. The clonal evolution of tumor cell populations. Science. 1976; 194:23-28.
51. Talmadge JE. Clonal selection of metastasis within the life history of a tumor. Cancer research. 2007; 67:11471-11475.
52. Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends in pharmacological sciences. 2012; 33:207-214.
53. Esteban MA, Tran MG, Harten SK, Hill P, Castellanos MC, Chandra A, Raval R, O'Brien TS, Maxwell PH. Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer research. 2006; 66:3567-3575.
54. Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, Baek JH, Semenza GL. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer research. 2006; 66:2725-2731.
55. Schlappack OK, Zimmermann A, Hill RP. Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. British journal of cancer. 1991; 64:663-670.
56. Suzuki A, Maeda T, Baba Y, Shimamura K, Kato Y. Acidic extracellular pH promotes epithelial mesenchymal transition in Lewis lung carcinoma model. Cancer cell international. 2014; 14:129.
57. Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer research. 2006; 66:6699-6707.
58. Martinez-Zaguilan R, Seftor EA, Seftor RE, Chu YW, Gillies RJ, Hendrix MJ. Acidic pH enhances the invasive behavior of human melanoma cells. Clinical & experimental metastasis. 1996; 14:176-186.
59. Cuzick J, Thorat MA, Bosetti C, Brown PH, Burn J, Cook NR, Ford LG, Jacobs EJ, Jankowski JA, La Vecchia C, Law M, Meyskens F, Rothwell PM, Senn HJ, Umar A. Estimates of benefits and harms of prophylactic use of aspirin in the general population. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015; 26:47-57.
60. Borsi E, Perrone G, Terragna C, Martello M, Zamagni E, Tacchetti P, Pantani L, Brioli A, Dico AF, Zannetti BA, Rocchi S, Cavo M. HIF-1alpha inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment. Experimental cell research. 2014; 328:444-455.
61. Burroughs SK, Kaluz S, Wang D, Wang K, Van Meir EG, Wang B. Hypoxia inducible factor pathway inhibitors as anticancer therapeutics. Future medicinal chemistry. 2013; 5:553-572.
62. Palayoor ST, Mitchell JB, Cerna D, Degraff W, John-Aryankalayil M, Coleman CN. PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells. International journal of cancer Journal international du cancer. 2008; 123:2430-2437.
63. Robertson BA, Rehage JS, Sih A. Ecological novelty and the emergence of evolutionary traps. Trends Ecol Evol. 2013; 28:552-560.
64. van der Sanden B, Appaix F, Berger F, Selek L, Issartel JP, Wion D. Translation of the ecological trap concept to glioma therapy: the cancer cell trap concept. Future oncology. 2013; 9:817-824.
65. Bladergroen BA, Siebum B, Siebers-Vermeulen KG, Van Kuppevelt TH, Poot AA, Feijen J, Figdor CG, Torensma R. In vivo recruitment of hematopoietic cells using stromal cell-derived factor 1 alpha-loaded heparinized three-dimensional collagen scaffolds. Tissue engineering Part A. 2009; 15:1591-1599.
66. Rabbany SY, Pastore J, Yamamoto M, Miller T, Rafii S, Aras R, Penn M. Continuous delivery of stromal cellderived factor-1 from alginate scaffolds accelerates wound healing. Cell transplantation. 2010; 19:399-408.
67. Uy GL, Rettig MP, Motabi IH, McFarland K, Trinkaus KM, Hladnik LM, Kulkarni S, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Vij R, Westervelt P, DiPersio JF. A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia. Blood. 2012; 119:3917-3924.
68. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994; 12:2229-2234.
69. Rastogi S, Gulia S, Bajpai J, Ghosh J, Gupta S. Oligometastatic breast cancer: A mini review. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology. 2014; 35:203-206.
70. Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V, Rey-Giraud F, Pradel LP, Feuerhake F, Klaman I, Jones T, Jucknischke U, Scheiblich S, Kaluza K, Gorr IH, Walz A, et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell. 2014; 25:846-859.
71. Tang X, Mo C, Wang Y, Wei D, Xiao H. Anti-tumour strategies aiming to target tumour-associated macrophages. Immunology. 2013; 138:93-104.